During Phase 2 of the study, data revealed consistent and sustained reductions in Intraocular Pressure (IOP), which were statistically significant (p-value < 0.05).
Ocular Therapeutix™ Mengumumkan Data Positif Fase 2 PAXTRAVA™ Glaukoma pada Pertemuan Tahunan American Society of Cataract and Refractive Surgery 2024